•
Mar 31, 2015

EyePoint Pharmaceuticals Q3 2015 Earnings Report

Total Revenue
$328K
Previous year: $2M
-83.6%
EPS
-$1.7
Previous year: -$0.8
+112.5%
Gross Profit
-$3.01M
Previous year: $1.99M
-251.5%
Cash and Equivalents
$23M
Previous year: $18.6M
+24.0%
Total Assets
$35.7M
Previous year: $26M
+37.2%

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals